臺灣血液透析實作指引 (TW HD IG)
0.0.2 - ci-build Taiwan, Province of China flag

臺灣血液透析實作指引 (TW HD IG) - Local Development build (v0.0.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: EPO 種類 ATC (Erythropoiesis-Stimulating Agent) - TTL Representation

Draft as of 2026-06-11

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:ValueSet ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "epo-type-atc-vs"] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet epo-type-atc-vs</b></p><a name=\"epo-type-atc-vs\"> </a><a name=\"hcepo-type-atc-vs\"> </a><ul><li>Include these codes as defined in <a href=\"http://www.whocc.no/atc\"><code>http://www.whocc.no/atc</code></a><span title=\"Version is not explicitly stated. No matching Code System found\"> version Not Stated (use latest from terminology server)</span><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>B03XA01</td><td>紅血球生成素 epoetin alfa/beta (erythropoietin)</td></tr><tr><td>B03XA02</td><td>達貝泊汀 alfa，Nesp (darbepoetin alfa)</td></tr><tr><td>B03XA03</td><td>甲氧基聚乙二醇 epoetin beta，Mircera (methoxy polyethylene glycol-epoetin beta)</td></tr><tr><td>B03XA</td><td>其他抗貧血製劑 (Other antianemic preparations)</td></tr></table></li></ul></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:url [
fhir:v "https://fhir.muen.tw/ig/hd/ValueSet/epo-type-atc-vs"^^xsd:anyURI ;
fhir:l <https://fhir.muen.tw/ig/hd/ValueSet/epo-type-atc-vs>
  ] ; # 
  fhir:version [ fhir:v "0.0.2"] ; # 
  fhir:name [ fhir:v "EpoTypeAtcVS"] ; # 
  fhir:title [ fhir:v "EPO 種類 ATC (Erythropoiesis-Stimulating Agent)"] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:experimental [ fhir:v true] ; # 
  fhir:date [ fhir:v "2026-06-11T17:55:18+08:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "沐恩生醫光電股份有限公司"] ; # 
  fhir:contact ( [
fhir:name [ fhir:v "沐恩生醫光電股份有限公司" ] ;
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://www.muenai.com/" ]     ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "[email protected]" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "紅血球生成素 (EPO/ESA) 之 WHO ATC 代碼。"] ; # 
  fhir:jurisdiction ( [
    ( fhir:coding [
fhir:system [
fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ;
fhir:l <urn:iso:std:iso:3166>       ] ;
fhir:code [ fhir:v "TW" ]     ] )
  ] ) ; # 
  fhir:compose [
    ( fhir:include [
fhir:system [
fhir:v "http://www.whocc.no/atc"^^xsd:anyURI ;
fhir:l <http://www.whocc.no/atc>       ] ;
      ( fhir:concept [
fhir:code [ fhir:v "B03XA01" ] ;
fhir:display [ fhir:v "紅血球生成素 epoetin alfa/beta (erythropoietin)" ]       ] [
fhir:code [ fhir:v "B03XA02" ] ;
fhir:display [ fhir:v "達貝泊汀 alfa，Nesp (darbepoetin alfa)" ]       ] [
fhir:code [ fhir:v "B03XA03" ] ;
fhir:display [ fhir:v "甲氧基聚乙二醇 epoetin beta，Mircera (methoxy polyethylene glycol-epoetin beta)" ]       ] [
fhir:code [ fhir:v "B03XA" ] ;
fhir:display [ fhir:v "其他抗貧血製劑 (Other antianemic preparations)" ]       ] )     ] )
  ] . #